DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
166. 弾性線維性仮性黄色腫
Pseudoxanthoma elasticum
Clinical trials
/
Disease details
臨床試験数
:
15
/
薬物数
:
27
- (
DrugBank
:
5
) /
標的遺伝子数
:
5
-
標的パスウェイ数
:
28
Search
2 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04441671
(
ClinicalTrials.gov
)
December 8, 2020
20/1/2020
Oral Pyrophosphate Absorption in PXE Disease
Oral
Disodiumpyrophosphate
(Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)
Pseudoxanthoma Elasticum
Drug:
Disodium Pyrophosphate
Tampere University Hospital
UMC Utrecht;Hungarian Academy of Sciences
Withdrawn
18 Years
80 Years
All
0
Phase 2
NULL
2
EUCTR2019-002109-24-FI
(
EUCTR
)
01/08/2019
01/07/2019
Oral Pyrophosphate Absorption in PXE Disease
Oral
Disodiumpyrophosphate
(Na2H2PPi) Absorption in Pseudoxanthoma Elasticum - Oral Pyrophosphate Absorption in PXE
Oral
Disodiumpyrophosphate
(Na2H2PPi) Absorption in Pseudoxanthoma Elasticum - Oral Pyrophosphate Abs ...
Pseudoxanthoma elasticum;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Pseudoxanthoma elasticum;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Disea ...
Product Name:
Disodiumpyrophosphate
Tampere University Hospital
NULL
Not Recruiting
Female: yes
Male: yes
10
Phase 2
Finland